AstraZeneca (XTER:ZEG) Land And Improvements : €0 Mil (As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is AstraZeneca Land And Improvements?

AstraZeneca's land and improvements for the quarter that ended in Mar. 2025 was €0 Mil.

AstraZeneca's quarterly land and improvements increased from Sep. 2024 (€0 Mil) to Dec. 2024 (€6,284 Mil) but then declined from Dec. 2024 (€6,284 Mil) to Mar. 2025 (€0 Mil).

AstraZeneca's annual land and improvements increased from Dec. 2022 (€5,135 Mil) to Dec. 2023 (€5,932 Mil) and increased from Dec. 2023 (€5,932 Mil) to Dec. 2024 (€6,284 Mil).

AstraZeneca Land And Improvements Historical Data

The historical data trend for AstraZeneca's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Land And Improvements Chart

AstraZeneca Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Land And Improvements

Get a 7-Day Free Trial

4,809.52

5,643.65

5,135.36

5,932.07

6,283.90

AstraZeneca Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Land And Improvements	Get a 7-Day Free Trial															-	-	-	6,283.90	-

AstraZeneca Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

AstraZeneca Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (XTER:ZEG) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

AZNCF:USA AZN:USA AZN:Sweden AZNN:Mexico AZNl:UK AZN:UK A1ZN34:Brazil AZNA:Austria AZN:Argentina

Address

1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA

Website

https://www.astrazeneca.com

A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.

AstraZeneca Headlines

No Headlines